Knocking-Out Concentrations of HIV-1-Specific Inhibitors Completely Suppress HIV-1 Infection and Prevent the Emergence of Drug-Resistant Virus

Jan Balzarini; Anna Karlsson; María‐Jesús Pérez‐Pérez; Marı́a-José Camarasa; De Clercq Erik

doi:10.1006/viro.1993.1513

Related publications

Article1998

Triple or quadruple drug therapy in naive HIV-1 seropositives does not prevent the selection of resistant virus in a subset of patients

Anne‐Mieke Vandamme, Kristien Van Vaerenbergh, JC Schmit, B. Schmidt, H Walter, Barbara Van Remoortel, Kristel Van Laethem, Myriam Witvrouw, Astrid Rascu, De Vroey, Mathias Grünke, Phillip A. Low, De Clercq Erik, Jan Desmyter, Thomas Harrer

Article1992

Highly potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by the HIV-1-specific reverse transcriptase inhibitors

Masanori Baba, Zeger Debyser, Shirô Shigeta, De Clercq Erik

Article1995

TSAO Derivatives: Highly Specific Inhibitors of Human Immunodeficiency Virus Type-1 (HIV-1) Replication

Marı́a-José Camarasa, Maria Péarez-Péarez, Sonsoles Velázquez, Ana San‐Félix, Rosa Álvarez, Simon T. Ingate, M. Luísa Jimeno, Anna Karlsson, De Clercq Erik, Jan Balzarini

Article1995

ChemInform Abstract: TSAO Derivatives: Highly Specific Inhibitors of Human Immunodeficiency Virus Type‐1 (HIV‐1) Replication

Marı́a-José Camarasa, María‐Jesús Pérez‐Pérez, Sonsoles Velázquez, Ana San‐Félix, Rosa Álvarez, Simon T. Ingate, M. Luísa Jimeno, Anna Karlsson, De Clercq Erik, Jan Balzarini

Article1993

Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.

Zeger Debyser, K De Vreese, P P Knops-Gerrits, Veerle Baekelandt, Ramagauri Bhikhabhai, B. Strandberg, Rudi Pauwels, Jozef Anné, Jan Desmyter, De Clercq Erik